ALEMBIC PHARMACEUTICALS
Back to Cashflow Statement
|
ALEMBIC PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-438 Cr | ₹-262 Cr | ₹-217 Cr | ₹-597 Cr | ₹155 Cr |
What is the latest Cash Flow from Financing Activities ratio of ALEMBIC PHARMACEUTICALS ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-438 Cr |
Mar2023 | ₹-262 Cr |
Mar2022 | ₹-217 Cr |
Mar2021 | ₹-597 Cr |
Mar2020 | ₹155 Cr |
How is Cash Flow from Financing Activities of ALEMBIC PHARMACEUTICALS Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-438 Cr | Negative | |
Mar2023 | ₹-262 Cr | Negative | |
Mar2022 | ₹-217 Cr | Negative | |
Mar2021 | ₹-597 Cr | Negative | |
Mar2020 | ₹155 Cr | - |
Compare Cash Flow from Financing Activities of peers of ALEMBIC PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ALEMBIC PHARMACEUTICALS | ₹20,935.0 Cr | 1.4% | -3.5% | 34.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹440,830.0 Cr | -2.2% | 1.7% | 41.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹155,644.0 Cr | -4.6% | -1.6% | 45.8% | Stock Analytics | |
CIPLA | ₹120,742.0 Cr | -2.8% | 1.8% | 15.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹114,366.0 Cr | -0.2% | 9.2% | 15.6% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,766.9 Cr | -0.9% | -0.1% | 41.1% | Stock Analytics |
ALEMBIC PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ALEMBIC PHARMACEUTICALS | 1.4% |
-3.5% |
34.9% |
SENSEX | -0.5% |
-4.4% |
9.5% |
You may also like the below Video Courses